Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Optimisation of telephone triage of callers with symptoms suggestive of acute cardiovascular disease in out-of-hours primary care: observational design of the Safety First study.

Erkelens DC, Wouters LT, Zwart DL, Damoiseaux RA, De Groot E, Hoes AW, Rutten FH.

BMJ Open. 2019 Jul 1;9(7):e027477. doi: 10.1136/bmjopen-2018-027477.

2.

Energy expenditure and dietary intake in professional football players in the Dutch Premier League: Implications for nutritional counselling.

Brinkmans NYJ, Iedema N, Plasqui G, Wouters L, Saris WHM, van Loon LJC, van Dijk JW.

J Sports Sci. 2019 Dec;37(24):2759-2767. doi: 10.1080/02640414.2019.1576256. Epub 2019 Feb 16.

PMID:
30773995
3.

Energy Expenditure during Extreme Endurance Exercise: The Giro d'Italia.

Plasqui G, Rietjens G, Lambriks L, Wouters L, Saris WHM.

Med Sci Sports Exerc. 2019 Mar;51(3):568-574. doi: 10.1249/MSS.0000000000001814.

PMID:
30363009
4.

Nine-year Clinical Performance of a HEMA-free One-step Self-etch Adhesive in Noncarious Cervical Lesions.

Peumans M, Wouters L, De Munck J, Van Meerbeek B, Van Landuyt K.

J Adhes Dent. 2018;20(3):195-203. doi: 10.3290/j.jad.a40630.

PMID:
29904752
5.

Optimal time-point for 68Ga-PSMA-11 PET/CT imaging in assessment of prostate cancer: feasibility of sterile cold-kit tracer preparation?

Beheshti M, Paymani Z, Brilhante J, Geinitz H, Gehring D, Leopoldseder T, Wouters L, Pirich C, Loidl W, Langsteger W.

Eur J Nucl Med Mol Imaging. 2018 Jul;45(7):1188-1196. doi: 10.1007/s00259-018-3970-y. Epub 2018 Feb 23.

PMID:
29476228
6.

Validation of the doubly labeled water method using off-axis integrated cavity output spectroscopy and isotope ratio mass spectrometry.

Melanson EL, Swibas T, Kohrt WM, Catenacci VA, Creasy SA, Plasqui G, Wouters L, Speakman JR, Berman ESF.

Am J Physiol Endocrinol Metab. 2018 Feb 1;314(2):E124-E130. doi: 10.1152/ajpendo.00241.2017. Epub 2017 Oct 3.

7.

Groin Pain Characteristics and Recurrence Rates: Three-year Results of a Randomized Controlled Trial Comparing Self-gripping Progrip Mesh and Sutured Polypropylene Mesh for Open Inguinal Hernia Repair.

Zwaans WAR, Verhagen T, Wouters L, Loos MJA, Roumen RMH, Scheltinga MRM.

Ann Surg. 2018 Jun;267(6):1028-1033. doi: 10.1097/SLA.0000000000002331.

PMID:
28594747
8.

Growth and endothelial function in the first 2 years of life.

Touwslager RN, Houben AJ, Tan FE, Gielen M, Zeegers MP, Stehouwer CD, Gerver WJ, Westerterp KR, Wouters L, Blanco CE, Zimmermann LJ, Mulder AL.

J Pediatr. 2015 Mar;166(3):666-71.e1. doi: 10.1016/j.jpeds.2014.11.059.

PMID:
25722270
9.

Neuroscientific evidence for defensive avoidance of fear appeals.

Kessels LT, Ruiter RA, Wouters L, Jansma BM.

Int J Psychol. 2014 Apr;49(2):80-8. doi: 10.1002/ijop.12036. Epub 2014 Jan 27.

10.

[The acrolentiginous melanoma: how to recognise and when to refer?].

Wouters LT, Thissen MR.

Ned Tijdschr Geneeskd. 2012;156(34):A4927. Review. Dutch.

PMID:
22914059
11.

Sustained medically unexplained physical symptoms in euthymic patients with recurrent depression: predictive value for recurrence and associations with omega 3- and 6 fatty acids and 5-HTTLPR?

Lok A, Assies J, Koeter MW, Bockting CL, Wouters LF, Mocking RJ, Schene AH.

J Affect Disord. 2012 Feb;136(3):604-11. doi: 10.1016/j.jad.2011.10.024. Epub 2011 Nov 17.

12.

The 5-year course of obsessive-compulsive symptoms and obsessive-compulsive disorder in first-episode schizophrenia and related disorders.

de Haan L, Sterk B, Wouters L, Linszen DH.

Schizophr Bull. 2013 Jan;39(1):151-60. doi: 10.1093/schbul/sbr077. Epub 2011 Jul 28.

13.

Circumferential skin creases, cleft palate, typical face, intellectual disability and growth delay: "circumferential skin creases Kunze type".

Wouters L, Rodriguez Rodriguez CM, Dapena EP, Poorten VV, Devriendt K, Van Esch H.

Eur J Med Genet. 2011 May-Jun;54(3):236-40. doi: 10.1016/j.ejmg.2011.01.003. Epub 2011 Jan 22.

PMID:
21262397
14.

Factor structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) in a large sample of patients with schizophrenia or related disorders and comorbid obsessive-compulsive symptoms.

Boyette L, Swets M, Meijer C, Wouters L; GROUP Authors.

Psychiatry Res. 2011 Apr 30;186(2-3):409-13. doi: 10.1016/j.psychres.2010.07.048. Epub 2010 Aug 30.

PMID:
20800902
15.

Dietary restraint and control over "wanting" following consumption of "forbidden" food.

Lemmens SG, Born JM, Rutters F, Schoffelen PF, Wouters L, Westerterp-Plantenga MS.

Obesity (Silver Spring). 2010 Oct;18(10):1926-31. doi: 10.1038/oby.2010.36. Epub 2010 Feb 25.

16.

Long-term effects of preventive cognitive therapy in recurrent depression: a 5.5-year follow-up study.

Bockting CL, Spinhoven P, Wouters LF, Koeter MW, Schene AH; DELTA Study Group.

J Clin Psychiatry. 2009 Dec;70(12):1621-8. doi: 10.4088/JCP.08m04784blu.

PMID:
20141705
17.

Revisiting the effect of quality of graphics on distance judgments in virtual environments: a comparison of verbal reports and blind walking.

Kunz BR, Wouters L, Smith D, Thompson WB, Creem-Regehr SH.

Atten Percept Psychophys. 2009 Aug;71(6):1284-93. doi: 10.3758/APP.71.6.1284.

PMID:
19633344
18.

Eating what you like induces a stronger decrease of 'wanting' to eat.

Lemmens SG, Schoffelen PF, Wouters L, Born JM, Martens MJ, Rutters F, Westerterp-Plantenga MS.

Physiol Behav. 2009 Sep 7;98(3):318-25. doi: 10.1016/j.physbeh.2009.06.008. Epub 2009 Jun 21.

PMID:
19545583
19.

Sexual dysfunction and hormonal changes in first episode psychosis patients on olanzapine or risperidone.

van Bruggen M, van Amelsvoort T, Wouters L, Dingemans P, de Haan L, Linszen D.

Psychoneuroendocrinology. 2009 Aug;34(7):989-95. doi: 10.1016/j.psyneuen.2009.01.013. Epub 2009 Mar 4.

PMID:
19264412
20.

Expression of retinoid-regulated genes in lamellar ichthyosis vs. healthy control epidermis: changes after oral treatment with liarozole.

Pavez Loriè E, Gånemo A, Borgers M, Wouters L, Blockhuys S, van de Plassche L, Törmä H, Vahlquist A.

Acta Derm Venereol. 2009;89(1):12-20. doi: 10.2340/00015555-0573.

21.

Topical treatment with CYP26 inhibitor talarozole (R115866) dose dependently alters the expression of retinoid-regulated genes in normal human epidermis.

Pavez Loriè E, Cools M, Borgers M, Wouters L, Shroot B, Hagforsen E, Törmä H, Vahlquist A.

Br J Dermatol. 2009 Jan;160(1):26-36. doi: 10.1111/j.1365-2133.2008.08895.x. Epub 2008 Oct 21.

PMID:
19016711
22.

Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.

Bergallo C, Jasovich A, Teglia O, Oliva ME, Lentnek A, de Wouters L, Zlocowski JC, Dukart G, Cooper A, Mallick R; 308 Study Group.

Diagn Microbiol Infect Dis. 2009 Jan;63(1):52-61. doi: 10.1016/j.diagmicrobio.2008.09.001. Epub 2008 Nov 5.

PMID:
18990531
23.

Efficacy of a single oral dose of 200 mg pramiconazole in vulvovaginal yeast infections: an exploratory phase IIa trial.

Donders G, Ausma J, Wouters L, Cauwenbergh G, Borgers M, Janssens D.

Acta Derm Venereol. 2008;88(5):462-6. doi: 10.2340/00015555-0494.

24.

The efficacy of oral treatment with pramiconazole in tinea pedis and tinea cruris/corporis: two exploratory phase IIa trials.

Decroix J, Ausma J, Cauwenbergh G, Borgers M, Wouters L.

Br J Dermatol. 2008 Apr;158(4):854-6. doi: 10.1111/j.1365-2133.2007.08420.x. Epub 2008 Jan 30. No abstract available.

PMID:
18241269
25.

A pilot study on seborrheic dermatitis using pramiconazole as a potent oral anti-Malassezia agent.

Piérard GE, Ausma J, Henry F, Vroome V, Wouters L, Borgers M, Cauwenbergh G, Piérard-Franchimont C.

Dermatology. 2007;214(2):162-9.

PMID:
17341867
26.

A modeling approach to the analysis of nerve regenerative experiments.

Van Sanden S, Wouters L, Burzykowski T, Molenberghs G, Van Remoortere M, Meert T, Bijnens L.

J Biopharm Stat. 2006;16(6):843-59.

PMID:
17146983
27.

Heat production and body temperature during cooling and rewarming in overweight and lean men.

Claessens-van Ooijen AM, Westerterp KR, Wouters L, Schoffelen PF, van Steenhoven AA, van Marken Lichtenbelt WD.

Obesity (Silver Spring). 2006 Nov;14(11):1914-20.

28.

Reliability and validity of the Yale-Brown Obsessive-Compulsive Scale in schizophrenia patients.

de Haan L, Hoogeboom B, Beuk N, Wouters L, Dingemans PM, Linszen DH.

Psychopharmacol Bull. 2006;39(1):25-30.

PMID:
17065972
29.

Prediction of recurrence in recurrent depression and the influence of consecutive episodes on vulnerability for depression: a 2-year prospective study.

Bockting CL, Spinhoven P, Koeter MW, Wouters LF, Schene AH; Depression Evaluation Longitudinal Therapy Assessment Study Group.

J Clin Psychiatry. 2006 May;67(5):747-55.

PMID:
16841624
30.

Evaluation of wireless determination of skin temperature using iButtons.

van Marken Lichtenbelt WD, Daanen HA, Wouters L, Fronczek R, Raymann RJ, Severens NM, Van Someren EJ.

Physiol Behav. 2006 Jul 30;88(4-5):489-97. Epub 2006 Jun 23.

PMID:
16797616
31.

Differential predictors of response to preventive cognitive therapy in recurrent depression: a 2-year prospective study.

Bockting CL, Spinhoven P, Koeter MW, Wouters LF, Visser I, Schene AH; DELTA study group.

Psychother Psychosom. 2006;75(4):229-36.

PMID:
16785772
32.

The ability of YSR scales to predict DSM/DISC-C psychiatric disorders among incarcerated male adolescents.

Vreugdenhil C, van den Brink W, Ferdinand R, Wouters L, Doreleijers T.

Eur Child Adolesc Psychiatry. 2006 Mar;15(2):88-96. Epub 2006 Feb 15.

PMID:
16463011
33.

Teaching statistical thinking to life scientists a case-based approach.

Vandenbroeck P, Wouters L, Molenberghs G, Van Gestel J, Bijnens L.

J Biopharm Stat. 2006;16(1):61-75.

PMID:
16440837
34.

Activity of the triazole antifungal r126638 as assessed by corneofungimetry.

Piérard-Franchimont C, Ausma J, Wouters L, Vroome V, Vandeplassche L, Borgers M, Cauwenbergh G, Piérard GE.

Skin Pharmacol Physiol. 2006;19(1):50-6. Epub 2005 Oct 20.

PMID:
16247249
35.

Preventing relapse/recurrence in recurrent depression with cognitive therapy: a randomized controlled trial.

Bockting CL, Schene AH, Spinhoven P, Koeter MW, Wouters LF, Huyser J, Kamphuis JH.

J Consult Clin Psychol. 2005 Aug;73(4):647-57.

PMID:
16173852
36.

Design and analysis of drug combination experiments.

Straetemans R, O'Brien T, Wouters L, Van Dun J, Janicot M, Bijnens L, Burzykowski T, Aerts M.

Biom J. 2005 Jun;47(3):299-308.

PMID:
16053254
37.

Psychotic symptoms among male adolescent detainees in The Netherlands.

Vreugdenhil C, Vermeiren R, Wouters LF, Doreleijers TA, van den Brink W.

Schizophr Bull. 2004;30(1):73-86.

PMID:
15176763
38.

Graphical exploration of gene expression data: a comparative study of three multivariate methods.

Wouters L, Göhlmann HW, Bijnens L, Kass SU, Molenberghs G, Lewi PJ.

Biometrics. 2003 Dec;59(4):1131-9.

PMID:
14969494
39.

Psychiatric disorders in a representative sample of incarcerated boys in the Netherlands.

Vreugdenhil C, Doreleijers TA, Vermeiren R, Wouters LF, van den Brink W.

J Am Acad Child Adolesc Psychiatry. 2004 Jan;43(1):97-104.

PMID:
14691365
40.

The immediate effects of a cervical lateral glide treatment technique in patients with neurogenic cervicobrachial pain.

Coppieters MW, Stappaerts KH, Wouters LL, Janssens K.

J Orthop Sports Phys Ther. 2003 Jul;33(7):369-78.

PMID:
12918862
41.

Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes.

de Longueville F, Atienzar FA, Marcq L, Dufrane S, Evrard S, Wouters L, Leroux F, Bertholet V, Gerin B, Whomsley R, Arnould T, Remacle J, Canning M.

Toxicol Sci. 2003 Oct;75(2):378-92. Epub 2003 Jul 25.

PMID:
12883083
42.

Substance use, substance use disorders, and comorbidity patterns in a representative sample of incarcerated male Dutch adolescents.

Vreugdenhil C, Van Den Brink W, Wouters LF, Doreleijers TA.

J Nerv Ment Dis. 2003 Jun;191(6):372-8.

PMID:
12826918
43.

Attitudes of patients toward the first psychotic episode and the start of treatment.

de Haan L, Peters B, Dingemans P, Wouters L, Linszen D.

Schizophr Bull. 2002;28(3):431-42.

PMID:
12645675
44.

Aberrant protective force generation during neural provocation testing and the effect of treatment in patients with neurogenic cervicobrachial pain.

Coppieters MW, Stappaerts KH, Wouters LL, Janssens K.

J Manipulative Physiol Ther. 2003 Feb;26(2):99-106.

PMID:
12584508
45.

What patient characteristics make clinicians recommend brief treatment?

Schaefer BA, Koeter MW, Wouters L, Emmelkamp PM, Schene AH.

Acta Psychiatr Scand. 2003 Mar;107(3):188-96.

PMID:
12580825
46.

Priorities and satisfaction on the help needed and provided in a first episode of psychosis. A survey in five European Family Associations.

de Haan L, Kramer L, van Raay B, Weir M, Gardner J, Akselson S, Ladinser E, McDaid S, Hernández Dols S, Wouters L.

Eur Psychiatry. 2002 Dec;17(8):425-33.

PMID:
12504258
47.

Fluvoxamine reduces responsiveness of HPA axis in adult female BPD patients with a history of sustained childhood abuse.

Rinne T, de Kloet ER, Wouters L, Goekoop JG, de Rijk RH, van den Brink W.

Neuropsychopharmacology. 2003 Jan;28(1):126-32.

49.
50.

[A study of the incidence and a descriptive analysis of adult non-tuberculous primary bacterial meningitis in a population in Argentina].

Barboza AG, Ioli P, Zamarbide I, Estragó MI, Castiñeiras F, de Wouters L.

Rev Neurol. 2002 Sep 16-30;35(6):508-12. Spanish.

Supplemental Content

Loading ...
Support Center